SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-24-000116
Filing Date
2024-11-14
Accepted
2024-11-14 16:18:15
Documents
18
Period of Report
2024-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20241112.htm   iXBRL 8-K 38117
2 EX-10.1 exhibit101_cspa11624.htm EX-10.1 182028
3 EX-10.2 exhibit102_rra11624.htm EX-10.2 204724
4 EX-10.3 exhibit103_cspa2-111324.htm EX-10.3 205647
5 EX-99.1 a8kq32024exhibit991.htm EX-99.1 97179
9 exicureimage1a10a.gif GRAPHIC 2794
  Complete submission text file 0001698530-24-000116.txt   971673

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20241112.xsd EX-101.SCH 1788
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20241112_lab.xml EX-101.LAB 21629
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20241112_pre.xml EX-101.PRE 12512
20 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20241112_htm.xml XML 2706
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 241462680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)